Up to 15pc hike in prices of medicines, 9pc for life-saving drugs approved

Published January 11, 2019
The drug manufacturing companies had been demanding 40pc increase in medicines' prices. — AFP/File
The drug manufacturing companies had been demanding 40pc increase in medicines' prices. — AFP/File

The Drug Regulatory Authority of Pakistan (Drap) on Friday, with the approval of the federal government, announced up to 15 per cent hike in the prices of medicines, apart from life-saving drugs.

Notification for increase in price of medicines.
Notification for increase in price of medicines.

According to a notification by Drap, available with DawnNewsTV, nine per cent hike has been approved in the prices of life-saving drugs, whereas a 15pc hike was approved in the prices of all other medicines.

"The revised maximum retail prices shall be printed on the label in the manner prescribed by the Drugs [Labelling and Packaging] Rules, 1986 and the manufacturers and importers of drugs shall furnish calculations of revised maximum retail price of drugs to the Division of Costing and Pricing of the Drug Regulatory Authority of Pakistan before affecting the increase," adds the notification.

The Pakistan Pharmaceutical Manufacturers Association (PPMA) Chairperson Zahid Saeed said that the drug manufacturing companies have been demanding 40pc increase in the prices of medicines.

He said that the increase was inevitable because of the increase in dollar's value, adding that PPMA was reviewing the contents of the notification.

Last year, a three-judge Supreme Court bench had taken up a suo motu notice about the increase in prices of drugs. In August, Chief Justice of Pakistan Mian Saqib Nisar had directed Drap to decide within 10 weeks all pending cases of pharmaceutical companies regarding medicine prices.

He had said the existing prices of all medicines would remain frozen till a decision on the cases. While rejecting a petition moved by one of the drug importers challenging the Drap policy, he observed that the court had no jurisdiction to interfere in policy matters of the government.

Follow Dawn Business on Twitter, LinkedIn, Instagram and Facebook for insights on business, finance and tech from Pakistan and across the world.

Opinion

Who bears the cost?

Who bears the cost?

This small window of low inflation should compel a rethink of how the authorities and employers understand the average household’s

Editorial

Internet restrictions
23 Dec, 2024

Internet restrictions

JUST how much longer does the government plan on throttling the internet is a question up in the air right now....
Bangladesh reset
23 Dec, 2024

Bangladesh reset

THE vibes were positive during Prime Minister Shehbaz Sharif’s recent meeting with Bangladesh interim leader Dr...
Leaving home
23 Dec, 2024

Leaving home

FROM asylum seekers to economic migrants, the continuing exodus from Pakistan shows mass disillusionment with the...
Military convictions
Updated 22 Dec, 2024

Military convictions

Pakistan’s democracy, still finding its feet, cannot afford such compromises on core democratic values.
Need for talks
22 Dec, 2024

Need for talks

FOR a long time now, the country has been in the grip of relentless political uncertainty, featuring the...
Vulnerable vaccinators
22 Dec, 2024

Vulnerable vaccinators

THE campaign to eradicate polio from Pakistan cannot succeed unless the safety of vaccinators and security personnel...